CD274 and neoplasm: Median PFS was 5.5 months (95% CI: 1.3–11.0) in patients with low PD-L1 expression (≥1%–<80% PD-L1+ tumour cells) and 15.2 months (95% CI: 1.3–NR) in patients with high expression [112].